Virtus ETF Advisers LLC - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 187 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.11 and the average weighting 0.0%.

Quarter-by-quarter ownership
Virtus ETF Advisers LLC ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$44,367
-62.0%
54,106
-27.8%
0.02%
-60.7%
Q4 2022$116,849
-6.5%
74,903
+3.3%
0.06%
+22.0%
Q3 2022$125,0000.0%72,540
+0.7%
0.05%
+8.7%
Q2 2022$125,000
+33.0%
72,014
+174.4%
0.05%
+9.5%
Q1 2022$94,000
-32.4%
26,244
-5.6%
0.04%
-19.2%
Q4 2021$139,000
-18.7%
27,793
+16.5%
0.05%
-30.7%
Q3 2021$171,000
-26.6%
23,857
-5.0%
0.08%
-21.9%
Q2 2021$233,000
-13.1%
25,105
-13.0%
0.10%
-15.0%
Q1 2021$268,000
+6.8%
28,845
+1.8%
0.11%
+8.7%
Q4 2020$251,000
+27.4%
28,339
-46.5%
0.10%
-75.2%
Q1 2019$197,000
-18.6%
52,943
-12.3%
0.42%
+922.0%
Q4 2018$242,000
-58.1%
60,398
-41.9%
0.04%
-31.7%
Q3 2018$578,000
-17.3%
104,004
-41.7%
0.06%
-90.3%
Q2 2018$699,000
-15.1%
178,365
+2.0%
0.62%
-13.4%
Q1 2018$823,000
+146.4%
174,782
+116.2%
0.71%
+70.4%
Q4 2017$334,000
+28.0%
80,850
+96.1%
0.42%
+1097.1%
Q3 2017$261,000
-11.2%
41,233
+10.1%
0.04%
-20.5%
Q2 2017$294,000
+10.1%
37,461
-7.1%
0.04%
-8.3%
Q1 2017$267,000
+5.5%
40,328
+10.6%
0.05%
-36.8%
Q4 2016$253,000
+12.9%
36,462
+51.6%
0.08%
-29.6%
Q3 2016$224,000
+0.9%
24,0580.0%0.11%
-34.5%
Q2 2016$222,000
-37.1%
24,058
-40.6%
0.16%
-66.0%
Q1 2016$353,00040,4870.49%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Green Alpha Advisors, LLC 570,049$221,7490.17%
GMT CAPITAL CORP 1,513,500$588,7520.02%
Cedar Brook Financial Partners, LLC 130,522$50,7730.01%
Arlington Capital Management, Inc. 27,735$10,7890.01%
GSA CAPITAL PARTNERS LLP 296,948$1160.01%
Keystone Financial Group 109,897$42,7510.01%
Hennion & Walsh Asset Management, Inc. 163,562$63,6260.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,149,974$447,3400.00%
Freedom Investment Management, Inc. 62,298$24,2340.00%
Renaissance Technologies 4,889,500$1,9020.00%
View complete list of INOVIO PHARMACEUTICALS INC shareholders